ICM
INGN icon

Invenomic Capital Management’s Inogen INGN Stock Holding History

Invenomic Capital Management’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-339,843
Closed -$1.77M – 192
2023
Q3 		$1.77M Sell
339,843
-39,411
-10% -$280K 0.07% 130
2023
Q2 		$4.38M Sell
379,254
-141,098
-27% -$1.66M 0.22% 89
2023
Q1 		$6.49M Buy
520,352
+140,098
+37% +$2.68M 0.37% 79
2022
Q4 		$7.49M Buy
380,254
+67,083
+21% +$1.44M 0.51% 68
2022
Q3 		$7.6M Sell
313,171
-293,351
-48% -$8.1M 0.65% 52
2022
Q2 		$14.7M Buy
606,522
+214,758
+55% +$5.71M 1.04% 29
2022
Q1 		$10.1M Buy
391,764
+226,338
+137% +$7.12M 1.08% 26
2021
Q4 		$5.62M Buy
+165,426
New +$6.01M 1.2% 25
2021
Q1 		– Sell
-11,166
Closed -$499K – 136
2020
Q4 		$499K Buy
11,166
+3,792
+51% +$131K 0.13% 95
2020
Q3 		$214K Buy
+7,374
New +$232K 0.12% 127

Other funds holding INGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invenomic Capital Management's INGN Position: Q4 2023 in Review

Invenomic Capital Management sold out of Inogen (INGN) in Q4 2023, closing a stake of 339,843 shares — an estimated $1.77M sold.

Invenomic Capital Management first reported a position in INGN in Q3 2020 and held it in 10 quarters. The position peaked at $14.7M in Q2 2022. 128 funds tracked by Wall St. Rank hold INGN as of Q4 2023.

  • Invenomic Capital Management reported no remaining Inogen position as of Q4 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 339,843 Inogen shares in Q4 2023, an estimated $1.77M.
  • Invenomic Capital Management first reported a position in Inogen in Q3 2020 and held it in 10 quarters.
  • Invenomic Capital Management's Inogen position peaked at $14.7M in Q2 2022.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q4 2023.

Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.